Tag: RuvembriTM
Biophytis presented the potential of RuvembriTM in the treatment of Duchenne muscular dystrophy – 03/08/2024 at 07:00
Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company specializing in the development of treatments that aim to slow down the degenerative…